论文部分内容阅读
目的:探索纳洛酮对早产儿中的极低出生体重儿(以下简称VLBwI)呼吸暂停的影响。方法:总结2001年1月～2005年10月在本院儿科新生儿病房住院的VLBWl7O例随机分为两纽,用药组40例,出生后前3天应用纳洛酮静点,对照组30例不用纳洛酮。结果,用药组VLBWl3天内呼吸停发生率为30％,对照组为60％。结论:应用纳洛酮可以有效降低VLBWI呼吸暂停发生率。
Objective: To explore the effect of naloxone on apnea in preterm infants with very low birth weight (VLBwI). Methods: From January 2001 to October 2005 in our pediatric neonatal ward hospitalized VLBWl7O cases were randomly divided into two New York, medication group 40 cases, the first 3 days after birth, naloxone static point, the control group of 30 patients No naloxone. Results, the medication group VLBWl3 days respiratory arrest rate was 30% in the control group was 60%. Conclusion: The application of naloxone can effectively reduce the incidence of apnea-hypopnea syndrome.